Clarus Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CRXTQ and buy or sell other stocks, ETFs, and their options commission-free!About CRXTQ
Clarus Therapeutics Holdings, Inc. is a pharmaceutical company, which engages in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications. The company was founded in 2004 and is headquartered in Los Angeles, CA.
CEORobert E. Dudley, PhD
CEORobert E. Dudley, PhD
Employees—
Employees—
HeadquartersLos Angeles, California
HeadquartersLos Angeles, California
Founded2004
Founded2004
Employees—
Employees—
CRXTQ Key Statistics
Market cap72.80K
Market cap72.80K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume12.65K
Average volume12.65K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.94
52 Week high$3.94
52 Week low$0.001
52 Week low$0.001
Stock Snapshot
As of today, Clarus Therapeutics(CRXTQ) shares are valued at $0.00. The company's market cap stands at 72.8K.
On 2026-08-15, Clarus Therapeutics(CRXTQ) stock opened at —, reached a high of —, and a low of —.
The Clarus Therapeutics(CRXTQ)'s current trading volume is 0, compared to an average daily volume of 12.65K.
During the past year, Clarus Therapeutics(CRXTQ) stock moved between $0.00 at its lowest and $3.94 at its peak.
During the past year, Clarus Therapeutics(CRXTQ) stock moved between $0.00 at its lowest and $3.94 at its peak.
People also own
Based on the portfolios of people who own CRXTQ. This list is generated using Robinhood data, and it’s not a recommendation.